Cytosorbents Crp
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 0.8 | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 0.4 | 0.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -624.8% | -574.3% | -887.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 51.2% | 51.8% | 52.3% | 51.9% | 52.6% | 58.8% | 61.7% | 64.8% | 65.0% | 63.0% | 62.4% | 63.3% | 66.0% | 67.7% | 69.6% | 68.6% | 69.2% | 72.3% | 72.7% | 75.1% | 75.3% | 74.0% | 73.8% | 69.3% | 61.1% | 56.8% | 53.6% | 55.3% | 60.5% | 61.9% | 67.0% | 69.6% | 67.7% | 76.6% | 75.3% | 74.6% | 78.7% | 71.5% | 71.0% | 71.6% | |
| -135.2% | -140.0% | -119.0% | -102.0% | -90.7% | -73.5% | -74.8% | -76.0% | -72.4% | -77.0% | -82.2% | -77.2% | -88.4% | -83.3% | -65.2% | -56.1% | -38.1% | -26.0% | -25.7% | -28.3% | -37.3% | -55.2% | -71.0% | -86.2% | -103.2% | -97.7% | -93.6% | -85.9% | -78.2% | -92.6% | -84.2% | -76.6% | -65.9% | -46.8% | -45.0% | -44.2% | -39.0% | -38.4% | -36.0% | -33.4% | |
| -134.4% | -138.1% | -118.2% | -86.5% | -71.5% | -57.5% | -61.1% | -80.4% | -78.4% | -85.0% | -93.7% | -80.2% | -95.8% | -84.6% | -67.7% | -57.2% | -32.2% | -19.7% | -20.4% | -23.7% | -37.6% | -59.6% | -75.3% | -98.5% | -122.8% | -101.7% | -92.2% | -76.2% | -65.1% | -84.8% | -82.3% | -78.1% | -55.8% | -57.9% | -45.3% | -27.0% | -28.6% | -22.1% | -31.9% | -48.9% | |
| -120.7% | -89.3% | -88.5% | -79.4% | -71.2% | -60.8% | -56.7% | -58.1% | -54.1% | -61.0% | -70.6% | -67.5% | -77.6% | -80.3% | -65.6% | -41.1% | -30.4% | -18.3% | -15.6% | -25.1% | -29.4% | -44.4% | -62.4% | -94.2% | -107.9% | -107.5% | -87.3% | -67.7% | -59.8% | -66.3% | -70.7% | -66.4% | -56.7% | -42.4% | -38.6% | -28.5% | -27.4% | -33.8% | -27.4% | -28.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -690.9% | – | – | -113.6% | -88.2% | -75.0% | -64.4% | -65.0% | -74.5% | -101.6% | -127.3% | -145.9% | -307.7% | -563.6% | -83.7% | -70.5% | -13.8% | -9.9% | -11.1% | -13.9% | -22.6% | -39.2% | -53.0% | -74.8% | -105.7% | -92.8% | -107.7% | -109.8% | -126.6% | -123.8% | -145.7% | -153.6% | -145.0% | -185.5% | -110.0% | -84.1% | -117.4% | -138.9% | -540.1% | – | |
| -87.7% | -116.9% | -131.2% | -40.7% | -37.6% | -31.9% | -32.9% | -40.1% | -43.7% | -52.6% | -61.7% | -59.1% | -72.2% | -70.4% | -40.3% | -34.8% | -10.7% | -8.7% | -9.8% | -10.6% | -16.8% | -27.4% | -35.3% | -49.9% | -66.4% | -51.9% | -54.2% | -50.4% | -49.3% | -54.1% | -58.6% | -48.1% | -39.4% | -43.5% | -31.5% | -20.3% | -23.1% | -18.6% | -29.2% | -48.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -1.5 | -0.3 | 1.7 | -6.5 | -5.4 | -7.3 | -7.2 | -5.5 | -15 | -12 | -9.3 | -5.6 | -0.5 | 3.2 | -11 | -19 | -72 | -71 | -68 | -65 | -61 | -52 | -43 | -30 | -22 | -17 | -14 | -8.0 | -3.2 | -8.7 | -3.8 | 5.6 | 8.6 | 11 | 3.1 | 4.7 | 7.5 | 11 | 13 | 13 | |
| 12.7% | -4.9% | -18.9% | 35.8% | 42.6% | 42.6% | 51.0% | 61.7% | 58.6% | 51.7% | 48.4% | 40.5% | 23.5% | 12.5% | 48.2% | 49.4% | 76.9% | 88.1% | 88.3% | 75.8% | 74.3% | 69.9% | 66.6% | 66.8% | 62.9% | 55.9% | 50.4% | 45.9% | 38.9% | 43.7% | 40.2% | 31.3% | 27.2% | 23.4% | 28.6% | 24.1% | 19.7% | 13.4% | 5.4% | -2.0% | |
| 3.6 | – | – | 1.3 | 1.1 | 1.0 | 1.0 | 0.9 | 0.5 | 0.6 | 0.7 | 0.9 | 2.3 | 4.5 | 0.7 | 0.7 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.8 | 1.1 | 1.3 | 1.0 | 1.3 | 1.7 | 2.9 | 8.0 | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -7.49 | -8.89 | -8.53 | -6.43 | -5.93 | -5.35 | -6.34 | -0.46 | -9.55 | -10.78 | -11.97 | -10.44 | -12.80 | -11.34 | -10.50 | -9.40 | -5.34 | -3.77 | -3.96 | -4.78 | -7.34 | -11.30 | -13.50 | -16.33 | -18.97 | -15.09 | -14.27 | -12.02 | -10.56 | -12.90 | -10.16 | -9.47 | -6.92 | -7.53 | -5.27 | -2.90 | -3.37 | -2.61 | -3.78 | -5.80 | |
| 5.57 | 6.44 | 7.22 | 7.44 | 8.30 | 9.31 | 10.37 | 0.58 | 12.19 | 12.69 | 12.78 | 13.02 | 13.36 | 13.40 | 15.51 | 16.45 | 16.60 | 19.18 | 19.36 | 20.18 | 19.53 | 18.95 | 17.92 | 16.58 | 15.44 | 14.85 | 15.48 | 15.78 | 16.23 | 15.22 | 12.35 | 12.13 | 12.41 | 13.01 | 11.64 | 10.75 | 11.79 | 11.80 | 11.86 | 11.85 | |
| 1.08 | -0.37 | -1.23 | 5.66 | 6.72 | 7.14 | 9.84 | 0.71 | 12.82 | 10.61 | 9.40 | 7.15 | 4.16 | 2.01 | 12.54 | 13.33 | 38.58 | 38.09 | 35.73 | 34.34 | 32.54 | 28.79 | 25.49 | 21.84 | 17.95 | 16.27 | 13.26 | 10.95 | 8.34 | 10.42 | 6.98 | 6.16 | 4.77 | 4.06 | 4.79 | 3.45 | 2.87 | 1.88 | 0.70 | -0.24 | |
| -6.72 | -5.75 | -6.39 | -5.91 | -5.90 | -5.66 | -5.88 | -0.33 | -6.59 | -7.74 | -9.02 | -8.78 | -10.37 | -10.76 | -10.17 | -6.76 | -5.05 | -3.51 | -3.02 | -5.07 | -5.74 | -8.41 | -11.18 | -15.61 | -16.65 | -15.96 | -13.51 | -10.68 | -9.70 | -10.09 | -8.73 | -8.06 | -7.04 | -5.52 | -4.50 | -3.06 | -3.23 | -3.99 | -3.25 | -3.32 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.